COMMUNIQUÉS West-GlobeNewswire

Treace to Report Second Quarter 2025 Financial Results on August 7, 2025
24/07/2025
PONTE VEDRA, Fla., July 24, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of [...]
Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025
24/07/2025
LONDON, July 24, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 29, 2025 at 8:30 a.m. Eastern [...]
Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq
24/07/2025
- Special Meeting of Stockholders to be Held Virtually on September 5, 2025 - - Live Stockholder Fireside Chat to be Scheduled to Answer Frequently Asked Stockholder Questions - - Nasdaq Hearings Panel Meeting Scheduled [...]
Celcuity Announces First Patient Dosed in Phase 3 VIKTORIA-2 Clinical Trial of Gedatolisib as a First-Line Treatment for HR+/HER2- Advanced Breast Cancer
24/07/2025
MINNEAPOLIS, July 24, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that the first patient has [...]
Cytokinetics to Announce Second Quarter Results On August 7, 2025
24/07/2025
SOUTH SAN FRANCISCO, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report second quarter results on August 7, 2025 at 4:00 PM Eastern Time. [...]
Revolution Medicines Announces Publication of a Peer-Reviewed Research Paper in Science on the Discovery and Development of Zoldonrasib, a RAS(ON) G12D-Selective Inhibitor
24/07/2025
REDWOOD CITY, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today [...]
Merakris Therapeutics Spotlights Investigational New Drug, MTX-001, with Innovation Showcase Win at 2025 Advanced Wound Care Summit
24/07/2025
MTX-001 recognized for its clinical and commercial potential for treating chronic non-healing venous leg ulcers (VLUs) RESEARCH TRIANGLE PARK, N.C., July 24, 2025 (GLOBE NEWSWIRE) -- Merakris Therapeutics announces it [...]
Cabometyx® approved in the EU for previously treated advanced neuroendocrine tumors
24/07/2025
Cabometyx ® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or metastatic neuroendocrine tumors, regardless of tumor site, grade or previous non- [...]
Approbation de Cabometyx® dans l’UE pour les tumeurs neuroendocrines avancées précédemment traitées
24/07/2025
Cabometyx ® est le premier et unique traitement systémique autorisé dans l’Union européenne pour les tumeurs neuroendocrines non résécables ou métastatiques précédemment traitées, indépendamment de la localisation de la [...]
Fairhaven Health Strengthens Women’s Health Commitment Beyond Fertility
24/07/2025
MIDDLETOWN, Conn., July 24, 2025 (GLOBE NEWSWIRE) -- As the world honors World IVF Day, Fairhaven Health — a company long recognized by reproductive health professionals for its fertility-focused supplements — is [...]
Omniscient and The Jacobs Institute, Inc. Announce Strategic Partnership to Pioneer Clinical Connectomics
24/07/2025
BUFFALO, N.Y., July 24, 2025 (GLOBE NEWSWIRE) -- Omniscient (o8t®), the global leader in connectomics, is proud to announce a groundbreaking partnership with The Jacobs Institute, Inc. (JI), a one-of-a-kind non-profit [...]
Guerbet : H1 2025 revenue
24/07/2025
H1 2025 revenue First-half activity H1 revenue of €387.8 million, down 5.4% at CER 1 and like-for-like 2 largely due to the fall in activity in France Sales at CER and on a like-for-like basis increased in EMEA [...]
Guerbet : Chiffre d’affaires du 1er semestre 2025
24/07/2025
Chiffre d’affaires du 1 er semestre 2025 Activité semestrielle Un chiffre d’affaires à mi-exercice de 387,8 M€, marquant un repli de 5,4% à TCC 1 et périmètre comparable 2 très largement dû à la baisse d’activité en [...]
Natural Brain Support Without the Crash: Lives Potions Introduces Plant-Based Cognitive Enhancement
24/07/2025
This Herbal Brain Booster supports short-term focus and long-term brain health, offering calm, clean mental energy without jitters or burnout Brooklyn, NY, July 24, 2025 (GLOBE NEWSWIRE) -- Lives Potions is making waves [...]
HealthSure 3X Launches Virtual In-Home Medical Services with Improved Access to Quality Care
24/07/2025
NEWARK, N.J., July 24, 2025 (GLOBE NEWSWIRE) -- HealthSure 3X, an online health solutions company headquartered in New Jersey, has introduced a fully integrated platform where patients can avail themselves of licensed [...]
Legal Muscle Supplements: Smart Bodybuilders in 2025 Use Legal Steroid Alternatives from CrazyBulk for Muscle Growth and Cutting
24/07/2025
New York City, NY, July 24, 2025 (GLOBE NEWSWIRE) -- Feedback from a recent survey shows that men and women who use supplements regularly view CrazyBulk as the best legal steroids and no.1 company brand for muscle- [...]
BeautyHealth to Report Second Quarter 2025 Financial Results on August 7, 2025
24/07/2025
LONG BEACH, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report second quarter 2025 financial results after market close [...]
Palm Health Opens Doors to New Patients Seeking Innovative Primary Care Solutions
24/07/2025
Palm Health Welcomes New Patients to Experience Cutting-Edge Direct Primary Care Jacksonville, FL, July 24, 2025 (GLOBE NEWSWIRE) -- Palm Health, Florida’s leading tech-forward Direct Primary Care (DPC) and medical [...]
Rumours of a Potential Takeover Offer for Bavarian Nordic A/S
24/07/2025
COPENHAGEN, Denmark, July 24, 2025 – Bavarian Nordic A/S (OMX: BAVA) has become aware of market rumours regarding a potential takeover offer for Bavarian Nordic A/S by a consortium consisting of Nordic Capital and [...]

Pages